Voriconazole

ApprovedCompleted
0 views this week 0 watching Active
Interest: 43/100
43
Hype Score

Development Stage

Pre-clinical
Phase 1
Phase 2
Phase 3
5
Approved
Indication / Disease

Candidiasis

Conditions

Candidiasis, Cryptococcosis, Aspergillosis

Trial Timeline

Apr 1, 2003 → May 1, 2004

About Voriconazole

Voriconazole is a approved stage product being developed by Pfizer for Candidiasis. The current trial status is completed. This product is registered under clinical trial identifier NCT00647907. Target conditions include Candidiasis, Cryptococcosis, Aspergillosis.

What happened to similar drugs?

4 of 20 similar drugs in Candidiasis were approved

Approved (4) Terminated (4) Active (13)

Hype Score Breakdown

Clinical
20
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (15)

NCT IDPhaseStatus
NCT01092832Phase 3Terminated
NCT00836875Phase 3Terminated
NCT00855101Phase 1Completed
NCT00721578Pre-clinicalCompleted
NCT00556998Phase 2Completed
NCT00455364ApprovedTerminated
NCT00300677ApprovedCompleted
NCT01660334Pre-clinicalCompleted
NCT01151085Pre-clinicalCompleted
NCT00288197ApprovedCompleted
NCT00159822Phase 2/3Completed
NCT00136968Phase 1Completed
NCT00143312ApprovedCompleted
NCT00174473Phase 1/2Completed
NCT00647907ApprovedCompleted

Competing Products

20 competing products in Candidiasis

See all competitors
ProductCompanyStageHype Score
MicafunginAstellas PharmaPhase 1
29
Isavuconazole + Caspofungin + VoriconazoleAstellas PharmaPhase 3
40
Micafungin + fluconazoleAstellas PharmaPhase 3
40
Micafungin (Mycamine)Astellas PharmaPhase 1
29
Fluconazole + MicafunginAstellas PharmaApproved
35
Micafungin + CaspofunginAstellas PharmaPhase 3
40
Micafungin + FluconazoleAstellas PharmaPhase 3
40
MicafunginAstellas PharmaPhase 2
35
micafungin + caspofunginAstellas PharmaPhase 3
40
micafungin + amphotericin B deoxycholateAstellas PharmaPhase 3
32
FK463Astellas PharmaPhase 2
35
Micafungin + Liposomal Amphotericin BAstellas PharmaPhase 3
40
SHR8008 + FluconazoleJiangsu Hengrui MedicinePhase 3
36
SHR8008 capsule + Fluconazole capsuleJiangsu Hengrui MedicinePhase 3
36
L-743,872MerckPre-clinical
26
CaspofunginMerckPhase 2
35
L-743,872MerckPhase 2
27
Caspofungin + Amphotericin B DeoxycholateMerckPhase 2
27
Caspofungin acetate + PlaceboMerckPhase 2
27
Caspofungin + Normal SalineMerckApproved
43